Rick Davis
Impact in
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
- Treatment of Major Depression
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Treatment of Major Depression 3
- Inflammatory mediators and NSAID effects 1
-
- Epilepsy research and treatment 2
In The Last Decade
Rick Davis
18 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 112
- Pharmacology 351
- Applied Microbiology and Biotechnology 37
- Psychiatry and Mental health 249
- Pharmacology 93
- Toxicology 50
Countries citing papers authored by Rick Davis
This map shows the geographic impact of Rick Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Davis more than expected).
Fields of papers citing papers by Rick Davis
This network shows the impact of papers produced by Rick Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Davis. The network helps show where Rick Davis may publish in the future.
Co-authors
The 16 scholars most cited alongside Rick Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 349 | |
| 2 | 1994 | 308 | |
| 3 | Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy. | 1994 | 242 |
| 4 | 1997 | 125 | |
| 5 | 1997 | 122 | |
| 6 | 1996 | 113 | |
| 7 | 1995 | 85 | |
| 8 | 1996 | 85 | |
| 9 | 1996 | 30 | |
| 10 | 1997 | 27 | |
| 11 | 1996 | 22 | |
| 12 | 1997 | 20 | |
| 13 | 1997 | 19 | |
| 14 | 1994 | 15 | |
| 15 | 1995 | 12 | |
| 16 | 1995 | 10 | |
| 17 | 1995 | 6 | |
| 18 | 1997 | 2 | |
| 19 | 1997 | 1 |
About Rick Davis
Rick Davis is a scholar working on Pharmacology, Psychiatry and Mental health, Cardiology and Cardiovascular Medicine, Internal Medicine and Endocrinology, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Treatment of Major Depression (3 papers), Epilepsy research and treatment (2 papers), Blood Pressure and Hypertension Studies (2 papers), Asthma and respiratory diseases (2 papers), Inflammatory mediators and NSAID effects (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Blood transfusion and management (1 paper). The work is most often cited by research in Pharmacology (351 citations), Applied Microbiology and Biotechnology (37 citations), Psychiatry and Mental health (249 citations), Pharmacology (93 citations) and Toxicology (50 citations). Frequent co-authors include Harriet M. Bryson, Anthony Markham, Julia A. Barman Balfour, Donna McTavish, Ruth Whittington, David H. Peters, Michelle I. Wilde, Diana M. Faulds, Jane C. Gillis and Heather D. Langtry. Their work appears in journals such as Drugs, PharmacoEconomics, CNS Drugs, Disease Management & Health Outcomes and Drugs & Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.